Zobrazeno 1 - 2
of 2
pro vyhledávání: '"M R, Di Notto"'
Autor:
E. Cazap, E. Triguboff, S. Breier, G. Uranga, M. R. Di Notto, L. Balbiani, A. Suarez, M. Trigo, G. Temperley, M.E. Pascual, F. Coppola, E. Mickiewicz, M. Rondinon, R. Estevez, S. Grasso, A. M. Bertoncin, D. Lewi, A. M. Alvarez, M. Ventriglia, C. Pazos, S. Jovtis
Publikováno v:
Breast Cancer Research and Treatment. 55:91-96
Purpose. To assess the response rate, survival, and toxicity of Taxol®(paclitaxel) as 1‐h infusion plus doxorubicin as first‐line treatment for patients with metastatic breast cancer (MBC). Patients and methods. Seventy‐six patients with untre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d4f659e0da689e1b3a674b8315d9519
https://doi.org/10.1023/a:1006194909859
https://doi.org/10.1023/a:1006194909859
Autor:
C, Pazos, E, Mickiewicz, M R, Di Notto, F, Cóppola, M, Ventriglia, S, Jovtis, L, Balbiani, D, Lewi, M, Róndinón, G, Témperley, M, Trigo, A M, Bertoncín, M, Pascual, G, Uranga, E, Cazap, S, Breier, S, Grasso, R, Estévez, E, Triguboff, A, Alvarez, A, Suárez
Publikováno v:
Breast cancer research and treatment. 55(1)
To assess the response rate, survival, and toxicity of Taxol (paclitaxel) as 1-h infusion plus doxorubicin as first-line treatment for patients with metastatic breast cancer (MBC).Seventy-six patients with untreated MBC were recruited. All of them ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1fcfa59bc39b548897eadb39b3d2b644
https://pubmed.ncbi.nlm.nih.gov/10472783
https://pubmed.ncbi.nlm.nih.gov/10472783